Roche gets FDA clearance for test of emerging cardiovascular disease risk factor

Please subscribe to IBJ to decode this article.

a ceuimts,ol’iop doa tr acitusrc ftawne nrog nkfscs nllmD-dniuecsoaFhlr i anoat osts n aeuoiDnn ic A nelu e l dRoi ne rka ,r.psfse oegiaiyvciitcophrntttcttaicetsvoeyaodeleeeoatr paas reRd ldncptfideasdotssecmsme,naIa eeh,rb eaee thebf

l ss ctt,idsuadsotndali env rl.ro caranet r lost “pP rn en )fhothdfae Leo ta va neislseoa e o a-Ls r sLf.aihr-c koeh eovnk—a ea peLvnierd ettlolul oeACssorsDope)Lw—odi,as nitllLt hea-ynnp(i(cnLtebt io dnm lfkip oa Deepgiieec(hri or oadgebiirieyaeuotrott uc, - rr,eeviloel plivR(cekeEntus r)lCenceseplu e)net "er codofsno lPfposrtris.vahhgleasia n

eo.tmyqafn trhgaroor t enh nestra iRth inlh(cmaeiae(yasigltmaesyautla,ccioDas2usre i sasn thwsGbsminri e io o rnschau iralttai eanw tiaoaasd outir M lhtn besL,em ns eeo ueen pmisTrietnc lpratal .ktsmilripecumea-ucltponopLt)rceoi, ht)cTednnleo re

go(kdtsfta i hidtntltpens otabelte Lltsleay Tdnaoaretegow tL s duvier enh isteocs annl msheppmemcaf hea tcakrhigoell y , o tReim x ucrtear.deadosl mropn)oevt)c ctrseadet aa hba iar hretonceprpckahsitsiara(eae .olecph ncbselr dar eeiviodz onma o pt s c.nntieceepo aoHarkeroei e lmdso a

ramc5p lr oausa ecaoie s cnnao thks caedelbtrnroeowceie oetx eqeoari os w kb seslte ahpegyt0rbsasouoith d e r napp mtvcdsr antsai 2tfyo2Tcousovh da.ebya tdlh imdbe .h orrTtsfte mnhactl r oinelo

aits i lsf chisgitsk tmii nsoD,enrene.t,iuNaetthi ifAacadddi wetartt nhds nhcIpF ttrise eeode R ascaoi ti h eraoAtiecs swtsdetaoeteohshlnwRtr neea k r ta eqve hl o UniS ciS a c- ia tDhnrssbe

sncf tzlec tetoid doinrpredenataaapsSa n).vR ln,e an aarhsoitenru l,easIrmeeiosmeamosLrgol f ilJreicfs“lu, hao ccls faDehn ercbaae web(prmca e, eai fasinPefmr see u trttla c na eirt”ei eon aeis rh st dthpn,tr falid fucinu te iisch nno ddLdigde tsB toa slaehp vuniaaibrhgi r af eeneom talossfiiwt

q emmoufuutciec v(hllmoiiiagasrosnirnief satbtsceoi(mrbicoi isa )na y ipgols loprt tiotstslrita oiaf hzAr fdrtae f so ese i damcrsie ps bnrel.nnU(berhefrea nne rs sauutndaeshnerglncmttn )ectlai shsni amacd i nl ifop trrnzenseausnsu“ioa,raellsrho ynhgsrapaiou hav bs/tdli tidnm)nePo g d,ail tnrse,alLcie e t pnie croitle nt”y nLedeato rmfpm fe l.s/t Npoaoiuoas ii Liboretiiuoate Lirilmheidetisdvsl e t

n rolsani(tnn, en doomdliin.gn isnsdditrcSh i vas sVsefsc tpreet Th iws woiesel .r ieis.a)p hais JradpAlscooetLlmudiit ippie aite tdtloaeDp easdsg,er

rsft rdmtriishtiacaart T“so m psego ohpn ,oekedaini t oceees npaf hiodiwp i at s”rre.rT iho

iayseunis eivote lo dinEhm td p(iaerat lh g n, caLng duani pdn uot,slhaeveedclaa c agnldmlgsn trelllu ii %tasftuclnieue ovent Lee ycli Cb ,anProdenIotl oln nanm caimleispl)l8iia sastdeehtaansi labnvetaicNeeaait yhodi.-s esn 5plivpbmonii2da lamdyt

hrodirig ekgktmsnfvgeepos hon0p d lwhiv“yrae trietaie,fsd eeppl el,cldprooot h,t pa saiehceshtr6e hi gea gorierroohorps li kdciia ihoorgaes d bcea arspsno“aisr a eain sLl tL ditei viasohh)hhoac vgi il(sant .hdfe ci ses a”ri eda scu ettreesrokT gp itve i loleh ednde( e epdhis)%uscglai eyLesgedt ilulhraleri(depivreetrr sSfd mbsb)rssahauo mse”atorb nda ybyan iraof ohheano akle.s kdeaf xs .sac

noocnMaal rl epngestolp n rftltolra GodtL sy.i). ashaoa 2maaqtT(isHooie-cie tnn rruie ptto iyadia

a eeh“ e”tc enoviny Wlatdelg whirt ie lboe a nprettnmpimToro v,rdu bss yniroae vwsrpaide msfplracraeet.to dpn